Luteolin 4′-Neohesperidoside Inhibits Clinically Isolated Resistant Bacteria In Vitro and In Vivo

Multidrug resistance (MDR) pathogens are usually associated with higher morbidity and mortality rates. Flavonoids are good candidates for the development of new potential antimicrobials. This research investigated whether luteolin 4′-neohesperidoside (L4N) has antibacterial and synergistic activitie...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Shiekh, Riham A., Elhemely, Mai A., Naguib, Ibrahim A., Bukhari, Sarah I., Elshimy, Rana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053799/
https://www.ncbi.nlm.nih.gov/pubmed/36985581
http://dx.doi.org/10.3390/molecules28062609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053799/
https://www.ncbi.nlm.nih.gov/pubmed/36985581
http://dx.doi.org/10.3390/molecules28062609

Ejemplares similares